Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Upgrades Immunovant to Buy

Guggenheim Upgrades Immunovant to Buy

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

February 13, 2023

1 minute read

Guggenheim analyst Yatin Suneja upgrades Immunovant (NASDAQ:IMVT) from Neutral to Buy.

Jim Cramer Says He’s ‘Going To Have To Wait’ On SoFi, But Recommends This ‘Great Little Industrial Company’

June 17, 8:39 AM

Jim Cramer can't recommend Twilio due to recent stock downgrade. He prefers Vistra Corp. and Constellation Energy Corp. for energy market.

September 11, 10:01 AM

FMC (NYSE:FMC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

January 17, 4:07 AM

Dalio's macro model identifies five major interconnected influences shaping the changing world order.

October 11, 9:39 AM

Boeing Company (NYSE: BA) has